Abstract
Disulphide bonds in secreted proteins are considered to be inert because of the oxidizing nature of the extracellular milieu. An exception to this rule is a reductase secreted by tumour cells that reduces disulphide bonds in the serine proteinase plasmin1,2. Reduction of plasmin initiates proteolytic cleavage in the kringle 5 domain and release of the tumour blood vessel inhibitor angiostatin3. New blood vessel formation or angiogenesis is critical for tumour expansion and metastasis4,5. Here we show that the plasmin reductase isolated from conditioned medium of fibrosarcoma cells is the glycolytic enzyme phosphoglycerate kinase6. Recombinant phosphoglycerate kinase had the same specific activity as the fibrosarcoma-derived protein. Plasma of mice bearing fibrosarcoma tumours contained several-fold more phosphoglycerate kinase, as compared with mice without tumours. Administration of phosphoglycerate kinase to tumour-bearing mice caused an increase in plasma levels of angiostatin, and a decrease in tumour vascularity and rate of tumour growth. Our findings indicate that phosphoglycerate kinase not only functions in glycolysis but is secreted by tumour cells and participates in the angiogenic process as a disulphide reductase.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stathakis, P., Fitzgerald, M., Matthias, L. J., Chesterman, C. N. & Hogg, P. J. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. J. Biol. Chem. 272, 20641–20645 (1997).
Stathakis, P. et al. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin. J. Biol. Chem. 274, 8910–8916 (1999).
O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328 (1994).
Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
Zetter, B. R. Angiogenesis and tumor metastasis. Ann. Rev. Med. 49 , 407–424 (1998).
Michelson, A. M., Markham, A. F. & Orkin, S. H. Isolation and DNA sequence of a full-length cDNA clone for human X chromosome-encoded phosphoglycerate kinase. Proc. Natl Acad. Sci. USA 80, 472– 476 (1983).
Gately, S. et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl Acad. Sci. USA 94, 10868–10872 ( 1997).
Cao, R. et al. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl Acad. Sci. USA 96, 5728–5733 ( 1999).
Jiang, X.-M., Fitzgerald, M., Grant, C. M. & Hogg, P. J. Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J. Biol. Chem. 274, 2416– 2423 (1999).
Vishwanatha, J. K., Jindal, H. K. & Davis, R. G. The role of primer recognition proteins in DNA replication: association with nuclear matrix in HeLa cells. J. Cell Sci. 101, 25–34 (1992).
Popanda, O., Fox, G. & Thielmann, H. W. Modulation of DNA polymerases α, δ and ε by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim. Biophys. Acta 1397, 102–117 (1998).
Ogino, T. et al. Involvement of a cellular glycolytic enzyme, phosphoglycerate kinase, in Sendai virus transcription. J. Biol. Chem. 274, 35999–36008 (1999).
Alloush, H. M., López-Ribot, J. L., Masten, B. J. & Chaffin, W. L. 3-phosphoglycerate kinase: a glycolytic enzyme protein present in the cell wall of Candida albicans. Microbiology 143, 321–330 (1997).
Ryan, H. E., Lo, J. & Johnson, R. S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005 –3015 (1998).
Gately, S. et al. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res. 56, 4887–4890 (1996).
Dong, Z., Kumar, R., Yang, X. & Fidler, I. J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801– 810 (1997).
Cornelius, L. A. et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161, 6845–6852 (1998).
O'Reilly, M. S., Wiederschain, D., Stetler-Stevenson, W. G., Folkman, J. & Moses, M. A. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. 274, 29568–29571 (1999).
Underwood, P. A. & Bean, P. A. Hazards of the limiting-dilution method of cloning hybridomas. J. Immunol. Methods 107, 119–128 ( 1988).
Darby, N. J. & Creighton, T. E. Functional properties of the individual thioredoxin-like domains of protein disulfide isomerase. Biochemistry 34, 11725–11735 (1995).
Kuntz, G. W. K. & Krietsch, W. K. G. Phosphoglycerate kinase from animal tissue. Methods Enzymol. 90, 103–110 (1982).
O'Reilly, M. S., Holmgren, L., Chen, C. & Folkman, J. Angiostatin induces and sustains dormancy of human tumors in mice. Nature Med. 2, 689–692 (1996).
Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149–153 ( 1995).
Acknowledgements
This work was supported by the National Health and Medical Research Council of Australia, the National Heart Foundation of Australia, the New South Wales Cancer Council and the NIH, USA. The authors gratefully acknowledge the support of J. Folkman, in whose laboratory the animal experiments were conducted, and thank D. Prox and C. Becker for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lay, A., Jiang, XM., Kisker, O. et al. Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase . Nature 408, 869–873 (2000). https://doi.org/10.1038/35048596
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35048596
This article is cited by
-
Regulation of phosphoglycerate kinase 1 and its critical role in cancer
Cell Communication and Signaling (2023)
-
Extracellular Pgk1 interacts neural membrane protein enolase-2 to improve the neurite outgrowth of motor neurons
Communications Biology (2023)
-
Differential proteomic comparison of breast cancer secretome using a quantitative paired analysis workflow
BMC Cancer (2019)
-
Potential new biomarkers for endometrial cancer
Cancer Cell International (2019)
-
Understanding protein multifunctionality: from short linear motifs to cellular functions
Cellular and Molecular Life Sciences (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.